ARTICLE | Finance
Bargain shopping
Biotech winners, losers in 3Q17
October 6, 2017 11:52 PM UTC
With all companies valued over $1 billion increasing a median of at least 16.8% in 1H17, investors went bargain shopping in the $500-$999 million tier in 3Q17. The group outperformed all other market cap bands, aided by outstanding after-market performance from a trio of new IPOs.
Companies valued over $10 billion increased a median of just 1.7% last quarter, though gainers outpaced decliners 14 to nine and $139 billion of equity value was created (see “Results by Market Cap”)...